MSFT 447.67 -0.4691% AAPL 208.14 0.3133% NVDA 118.11 -6.684% GOOGL 179.22 -0.2282% GOOG 180.79 0.294% AMZN 185.57 -1.8564% META 498.91 0.8347% AVGO 1592.21 -4.0045% TSLA 182.58 -0.235% TSM 167.81 -3.5353% LLY 890.11 0.7048% V 276.3 0.3924% JPM 198.88 1.3143% UNH 489.98 1.5313% NVO 142.28 0.2254% WMT 68.9 1.4578% LVMUY 155.41 1.3169% XOM 114.04 2.9614% LVMHF 780.0 1.9608% MA 456.96 0.4639%

Lifeline Biotechnologies Inc

Healthcare US LLBO

0.0004USD
-(-%)

Last update at 2024-06-21T13:30:00Z

Day Range

0.00040.0004
LowHigh

52 Week Range

0.00010.0006
LowHigh

Fundamentals

  • Previous Close 0.0004
  • Market Cap10.99M
  • Volume0
  • P/E Ratio-
  • Dividend Yield-%
  • Revenue TTM0.00000M
  • Revenue Per Share TTM-
  • Gross Profit TTM 0.00000M
  • Diluted EPS TTM-

Financials

Income Statement

Balancesheet

Change in Cash

Total Operating Cash

Dividends Paid

Breakdown 2009-12-31 2004-12-31 2003-12-31 2002-12-31
Type yearly yearly yearly yearly
Date 2009-12-31 2004-12-31 2003-12-31 2002-12-31
Income before tax -0.57427M -1.59514M -1.08535M -0.85048M
Minority interest - - - -
Net income -0.57427M -1.74117M -0.85488M -0.85996M
Selling general administrative 0.22M 0.90M 0.64M 0.47M
Selling and marketing expenses - - - -
Gross profit 0.00000M 0.05M 0.01M 0.00000M
Reconciled depreciation - - - -
Ebit -0.56288M -1.28696M -0.97707M -0.85125M
Ebitda - - - -
Depreciation and amortization - - - -
Non operating income net other - - - -
Operating income -0.56288M -1.28696M -0.97707M -0.85125M
Other operating expenses - - - -
Interest expense 0.00000M 0.00000M 0.00000M 0.00000M
Tax provision - - - -
Interest income - - - -
Net interest income - - - -
Extraordinary items - - - -
Non recurring - - - -
Other items - - - -
Income tax expense 0.00000M 0.00000M 0.00000M 0.00000M
Total revenue 0.00000M 0.10M 0.03M 0.00000M
Total operating expenses 0.56M 1.39M 1.01M 0.85M
Cost of revenue 0.00000M 0.05M 0.02M 0.00000M
Total other income expense net -0.01139M -0.30818M -0.10828M 0.00078M
Discontinued operations - -0.14603M 0.23M -0.00948M
Net income from continuing ops -0.57427M -1.59514M -1.08535M -0.85048M
Net income applicable to common shares -0.57427M -1.74117M -0.85488M -0.85996M
Preferred stock and other adjustments - - - -
Breakdown 2009-12-31 2004-12-31 2003-12-31
Type yearly yearly yearly
Date 2009-12-31 2004-12-31 2003-12-31
Total assets 6.72M 0.69M 1.04M
Intangible assets 0.14M 0.13M 0.06M
Earning assets - - -
Other current assets - - -
Total liab 0.62M 1.09M 0.38M
Total stockholder equity 6.11M -0.40746M 0.66M
Deferred long term liab 0.12M - -
Other current liab - - -
Common stock 0.03M 0.02M 0.00630M
Capital stock - - -
Retained earnings -12.17309M -11.41362M -9.67245M
Other liab 0.10M - -
Good will - - -
Other assets 0.93M 0.06M 0.00775M
Cash 0.60M 0.18M 0.24M
Cash and equivalents - - -
Total current liabilities 0.07M 0.15M 0.18M
Current deferred revenue - - -
Net debt - - -
Short term debt 0.03M 0.94M 0.19M
Short long term debt 0.03M 0.94M 0.19M
Short long term debt total - - -
Other stockholder equity - - -
Property plant equipment 0.05M 0.09M 0.11M
Total current assets 0.60M 0.40M 0.86M
Long term investments 5.00M - -
Net tangible assets 5.96M -0.54140M 0.60M
Short term investments - - -
Net receivables - - 0.56M
Long term debt 0.45M 0.94M 0.19M
Inventory - 0.22M -
Accounts payable 0.01M 0.15M 0.18M
Total permanent equity - - -
Noncontrolling interest in consolidated entity - - -
Temporary equity redeemable noncontrolling interests - - -
Accumulated other comprehensive income - - -
Additional paid in capital - - -
Common stock total equity - - -
Preferred stock total equity - - -
Retained earnings total equity - - -
Treasury stock - - -
Accumulated amortization - - -
Non currrent assets other - - -
Deferred long term asset charges - - -
Non current assets total - - -
Capital lease obligations - - -
Long term debt total - - -
Breakdown 2009-12-31 2004-12-31 2003-12-31 2002-12-31
Type yearly yearly yearly yearly
Date 2009-12-31 2004-12-31 2003-12-31 2002-12-31
Investments - - - -
Change to liabilities 0.00000M -0.03051M 0.07M -0.06152M
Total cashflows from investing activities - -0.16152M -0.62522M 0.00240M
Net borrowings - 0.50M -0.10200M 0.04M
Total cash from financing activities - 1.73M 1.00M 0.80M
Change to operating activities - 0.00326M 0.49M 0.49M
Net income -0.57427M -1.74117M -0.85488M -0.85996M
Change in cash - -0.06218M 0.24M -0.05321M
Begin period cash flow - - - -
End period cash flow - - - -
Total cash from operating activities - -1.63329M -0.13141M -0.86021M
Issuance of capital stock - - - -
Depreciation - 0.06M 0.05M 0.05M
Other cashflows from investing activities - - -0.56364M -0.56364M
Dividends paid - - - -
Change to inventory - -0.21735M -0.10865M -0.10865M
Change to account receivables - - - -
Sale purchase of stock - 0.67M 0.98M 0.76M
Other cashflows from financing activities - 0.56M 0.12M 0.12M
Change to netincome - 0.29M 0.21M 0.01M
Capital expenditures 0.00000M 0.04M 0.01M 0.02M
Change receivables - - - -
Cash flows other operating - - - -
Exchange rate changes - - - -
Cash and cash equivalents changes - - - -
Change in working capital - - - -
Stock based compensation - - - -
Other non cash items - - - -
Free cash flow - - - -

Peer Comparison

Sector: Healthcare Industry: Medical Devices

Company Change (USD) Price (USD) Trailing PE (x) Forward PE (x) Price Sales TTM (x) Price to Book Value (x)
LLBO
Lifeline Biotechnologies Inc
- -% 0.0004 - - - -
ABT
Abbott Laboratories
-0.42 0.40% 105.30 37.15 23.15 4.67 4.97 4.88 19.38
SYK
Stryker Corporation
-3.57 1.04% 339.07 44.07 24.94 5.51 6.12 6.05 25.73
MDT
Medtronic PLC
-0.6 0.73% 81.04 26.60 15.87 3.35 2.08 3.90 14.12
BSX
Boston Scientific Corp
-1.0 1.29% 76.71 68.17 24.57 5.85 4.26 6.46 26.80

Reports Covered

Stock Research & News

Profile

Lifeline Biotechnologies, Inc. operates as a medical technology company in the United States. Its technologies focus on prevention, early diagnosis, and quick recovery of various diseases. The company offers First Warning System, a non-invasive, non-compressive, and non-radiogenic device used in assisting the early discovery of breast tissue abnormalities in women. It also provides Mastascope, a hand held endoscope designed to enter the breast nipple via one of its milk ducts, thus permitting the physician to visualize the interior aspects of the breast; and OVASCOPE, an ultra slim endoscope to directly visualize the ovarian surface in the search for cancer. The company also has operations in Europe. Lifeline Biotechnologies, Inc. was incorporated in 1981 and is headquartered in Reno, Nevada.

Lifeline Biotechnologies Inc

1325 Airmotive Way, Reno, NV, United States, 89502

Key Executives

Name Title Year Born
Mr. James D. Holmes CPA, MBA Chairman, Chief Exec. Officer and Treasurer NA
Dr. William H. Reeves Ph.D. Founder NA
Dr. Louis G. Keith M.D., Ph.D. VP, Medical Director, Sec. and Director NA

Disclaimer - Data Powered by EOD Historical Data (“EODHD”). All CFDs (stocks, indices, mutual funds, ETFs), and Forex are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. EODHD is not using exchanges data feeds for the pricing data, EODHD is using OTC, peer to peer trades and trading platforms over 100+ sources, EODHD is aggregating its data feeds via VWAP method. Therefore, EOD Historical Data doesn’t bear any responsibility for any trading losses you might incur as a result of using this data. EOD Historical Data or anyone involved with EOD Historical Data will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible. EOD Historical Data does not give any warranties (including, without limitation, as to merchantability or fitness for a particular purpose or use).